
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4451393
[patent_doc_number] => 07964717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'RNAi probes targeting cancer-related proteins'
[patent_app_type] => utility
[patent_app_number] => 11/276300
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 32
[patent_no_of_words] => 7660
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11276300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/276300 | RNAi probes targeting cancer-related proteins | Feb 22, 2006 | Issued |
Array
(
[id] => 5620027
[patent_doc_number] => 20060189561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'RNAi expression constructs with liver-specific enhancer/promoter'
[patent_app_type] => utility
[patent_app_number] => 11/355516
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13479
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11355516
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/355516 | RNAi expression constructs with liver-specific enhancer/promoter | Feb 15, 2006 | Issued |
Array
(
[id] => 5253912
[patent_doc_number] => 20070135368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Cell-to-cell transmission of siRNA induced gene silencing in mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 11/352513
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6332
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135368.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352513 | Cell-to-cell transmission of siRNA induced gene silencing in mammalian cells | Feb 9, 2006 | Abandoned |
Array
(
[id] => 4886522
[patent_doc_number] => 20080260854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Sirna Molecules for the Treatment of Blood Vessels'
[patent_app_type] => utility
[patent_app_number] => 11/814213
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8695
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260854.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814213
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814213 | siRNA molecules for the treatment of blood vessels | Jan 18, 2006 | Issued |
Array
(
[id] => 10008065
[patent_doc_number] => 09051572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-09
[patent_title] => 'Modulators of Itch ubiquitinase activity'
[patent_app_type] => utility
[patent_app_number] => 11/813585
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 19
[patent_no_of_words] => 27679
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11813585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813585 | Modulators of Itch ubiquitinase activity | Jan 18, 2006 | Issued |
Array
(
[id] => 5601774
[patent_doc_number] => 20060292119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Modulation of negative immune regulators and applications for immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 11/335736
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 113
[patent_figures_cnt] => 113
[patent_no_of_words] => 56794
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292119.pdf
[firstpage_image] =>[orig_patent_app_number] => 11335736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/335736 | Modulation of negative immune regulators and applications for immunotherapy | Jan 18, 2006 | Issued |
Array
(
[id] => 4759919
[patent_doc_number] => 20080312145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Agent for Regulating Bone Formation'
[patent_app_type] => utility
[patent_app_number] => 11/721834
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8726
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312145.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721834
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721834 | Agent for Regulating Bone Formation | Dec 14, 2005 | Abandoned |
Array
(
[id] => 4545108
[patent_doc_number] => 07960102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Regulated aptamer therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/291610
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13754
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291610
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291610 | Regulated aptamer therapeutics | Nov 29, 2005 | Issued |
Array
(
[id] => 5596193
[patent_doc_number] => 20060160110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Methods of designing small interfering RNAs, antisense polynucleotides, and other hybridizing polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/290628
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17460
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160110.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290628
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290628 | Methods of designing small interfering RNAs, antisense polynucleotides, and other hybridizing polynucleotides | Nov 28, 2005 | Abandoned |
Array
(
[id] => 5648336
[patent_doc_number] => 20060134068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity'
[patent_app_type] => utility
[patent_app_number] => 11/270796
[patent_app_country] => US
[patent_app_date] => 2005-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24672
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134068.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270796 | Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity | Nov 7, 2005 | Abandoned |
Array
(
[id] => 5632277
[patent_doc_number] => 20060148747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Antisense antiviral compound and method for treating influenza viral infection'
[patent_app_type] => utility
[patent_app_number] => 11/259434
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13963
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148747.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259434
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259434 | Antisense antiviral compound and method for treating influenza viral infection | Oct 24, 2005 | Issued |
Array
(
[id] => 5678530
[patent_doc_number] => 20060183886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Ligands to enhance cellular uptake of biomolecules'
[patent_app_type] => utility
[patent_app_number] => 11/256476
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 24433
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256476
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256476 | Ligands to enhance cellular uptake of biomolecules | Oct 20, 2005 | Abandoned |
Array
(
[id] => 4792679
[patent_doc_number] => 20080293653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Method of treating autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 11/247331
[patent_app_country] => US
[patent_app_date] => 2005-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20399
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11247331
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/247331 | Method of treating autoimmune diseases | Oct 11, 2005 | Abandoned |
Array
(
[id] => 12192968
[patent_doc_number] => 09896687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure'
[patent_app_type] => utility
[patent_app_number] => 11/233495
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15422
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11233495
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233495 | Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure | Sep 20, 2005 | Issued |
Array
(
[id] => 8232790
[patent_doc_number] => 08198235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response'
[patent_app_type] => utility
[patent_app_number] => 11/575073
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8466
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575073
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575073 | Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response | Sep 8, 2005 | Issued |
Array
(
[id] => 5801261
[patent_doc_number] => 20060035815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Pharmaceutical compositions for delivery of ribonucleic acid to a cell'
[patent_app_type] => utility
[patent_app_number] => 11/223699
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27772
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035815.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223699
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223699 | Pharmaceutical compositions for delivery of ribonucleic acid to a cell | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5710982
[patent_doc_number] => 20060052327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Cell specific gene silencing using cell-specific promoters in vitro and in vivo'
[patent_app_type] => utility
[patent_app_number] => 11/221096
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10305
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052327.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221096 | Cell specific gene silencing using cell-specific promoters in vitro and in vivo | Sep 6, 2005 | Abandoned |
Array
(
[id] => 5591432
[patent_doc_number] => 20060040884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition'
[patent_app_type] => utility
[patent_app_number] => 11/191875
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26538
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11191875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/191875 | Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition | Jul 27, 2005 | Abandoned |
Array
(
[id] => 5441419
[patent_doc_number] => 20090093058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'CELL TRANSFECTION ARRAY FOR INTRODUCTION OF NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 11/996002
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4730
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093058.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996002
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996002 | Cell transfection array for introduction of nucleic acid | Jul 21, 2005 | Issued |
Array
(
[id] => 5880920
[patent_doc_number] => 20060030003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Composition and method for introduction of RNA interference sequences into targeted cells and tissues'
[patent_app_type] => utility
[patent_app_number] => 11/186609
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5276
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20060030003.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186609
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186609 | Composition and method for introduction of RNA interference sequences into targeted cells and tissues | Jul 20, 2005 | Abandoned |